Macrophage-derived lncRNAs in cancer: regulators of tumor progression and therapeutic targets
Medical Oncology,
Journal Year:
2025,
Volume and Issue:
42(4)
Published: March 6, 2025
Language: Английский
Exosomes: from basic research to clinical diagnostic and therapeutic applications in cancer
Salomé Araujo‐Abad,
No information about this author
José Berná,
No information about this author
Elena Lloret-Lopez
No information about this author
et al.
Cellular Oncology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 19, 2024
Language: Английский
The mechanism of action and therapeutic potential of tumor-associated macrophages in tumor immune evasion
Kehua Wang,
No information about this author
Xu Zhang,
No information about this author
Aiqin Li
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 22, 2025
Tumor-associated
macrophages
(TAMs)
play
a
multifaceted
role
in
tumor
progression.
As
specialized
immune
cells,
are
capable
of
phagocytosis
and
digesting
foreign
substances,
as
well
removing
harmful
substances
including
cellular
debris
cells.
Under
specific
pathological
conditions,
circulating
monocytes
can
be
recruited
into
the
microenvironment
differentiate
TAMs.
Macrophages
generally
polarized
two
distinct
subpopulations:
classically
activated
(M1)
alternatively
(M2).
TAMs
constitute
significant
proportion
mononuclear
leukocyte
population
solid
tumors,
exhibiting
complex
dualistic
relationship
with
Substantial
evidence
indicates
that
interact
facilitating
their
evasion
while
promoting
invasion
metastasis.
This
review
focuses
on
mechanism
regulation
response
to
various
macrophage-based
tumor-targeted
therapeutic
strategies.
It
will
provide
reference
for
research
macrophage-centered
therapy
strategies
application
clinical
practice.
Language: Английский
Spatial transcriptomics: a new frontier in accurate localization of breast cancer diagnosis and treatment
Yang Zhang,
No information about this author
Shuhua Gong,
No information about this author
Xiaofei Liu
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Oct. 8, 2024
Breast
cancer
is
one
of
the
most
prevalent
cancers
in
women
globally.
Its
treatment
and
prognosis
are
significantly
influenced
by
tumor
microenvironment
heterogeneity.
Precision
therapy
enhances
efficacy,
reduces
unwanted
side
effects,
maximizes
patients’
survival
duration
while
improving
their
quality
life.
Spatial
transcriptomics
significant
importance
for
precise
breast
cancer,
playing
a
critical
role
revealing
internal
structural
differences
tumors
composition
microenvironment.
It
offers
novel
perspective
studying
spatial
structure
cell
interactions
within
tumors,
facilitating
more
effective
personalized
treatments
cancer.
This
article
will
summarize
latest
findings
diagnosis
from
transcriptomics,
focusing
on
revelation
microenvironment,
identification
new
therapeutic
targets,
enhancement
disease
diagnostic
accuracy,
comprehension
progression
metastasis,
assessment
drug
responses,
creation
high-resolution
maps
cells,
representation
heterogeneity,
support
clinical
decision-making,
particularly
elucidating
immunotherapy
correlation
with
outcomes.
Language: Английский